BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22356286)

  • 21. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
    Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems Associated with Deprescribing of Proton Pump Inhibitors.
    Helgadottir H; Bjornsson ES
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.
    Kanno T; Moayyedi P
    Curr Gastroenterol Rep; 2019 Dec; 21(12):65. PubMed ID: 31807948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?].
    von Rahden BH; Scheurlen M; Filser J; Stein HJ; Germer CT
    Chirurg; 2012 Jan; 83(1):38-44. PubMed ID: 21909830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitors: placing putative adverse effects in proper perspective.
    Schubert ML
    Curr Opin Gastroenterol; 2019 Nov; 35(6):509-516. PubMed ID: 31433315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
    Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
    Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety concerns with proton pump inhibitors.
    Ali T; Roberts DN; Tierney WM
    Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
    Koyyada A
    Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S27-32. PubMed ID: 19262544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing PPIs.
    Drug Ther Bull; 2017 Oct; 55(10):117-120. PubMed ID: 29021249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.